Abstract

Extracorporeal membrane oxygenation (ECMO) is a life saving treatment for patients with severe respiratory failure. We present a case of a young child with invasive Panton Valentine leukocidin-producing Staphylococcus aureus infection, which is responsible for severe and invasive infection with a high mortality rate, commonly associated with necrotizing pneumonia. Our patient presented with septic shock and necrotizing pneumonia leading to severe respiratory failure, refrac-tory to conventional ventilation means. After 1-day of treatment, venovenous ECMO (VV ECMO) was successfully instituted and inotropic support was gradually decreased. Acute renal failure was managed with peritoneal dialysis and intermittent venovenous hemofiltration. The patient was weaned from ECMO 9-days later and was mechanically ventilated for another 3 weeks. Necrotizing pneumonia with pleuropulmonary complications was finally managed by videothoracoscopy with evacuation of debris and partial pleural decortication. Osteomyelitis was confirmed by positron emission tomography – computed tomography (PET-CT) and was surgically treated. The child was treated with antistaphylococcal antibiotic therapy for 54 days. Finally, he was discharged to a rehabilitation center without supplemental oxygen and with his neurologic status at his baseline. Our case shows that VV ECMO can be applied to children with severe bacterial pneumonia resistant to conventional ventilation strategies and with moderate circulatory failure.

Highlights

  • Extracorporeal membrane oxygenation (ECMO) is a life saving treatment for patients with severe respiratory failure, when conventional means of support are inadequate

  • This is the first case of severe pneumonia in a child managed by venovenous ECMO (VV ECMO) in our institution, which is the only institution in Slovenia capable of providing extracorporeal life support techniques in children

  • Today ECMO is used for three main distinctive groups of patients: neonates with respiratory failure refractory to conventional management, neonates and children with circulatory failure and for children with respiratory failure. [1,2,7] Respiratory failure in children was the latest indication introduced for ECMO and use of ECMO for this group of patients has increased steadily, leveling off in the nineties, but recently it has been reported to be slightly increasing again. [2,8] The survival of pediatric respiratory ECMO is 50–55%. [8] There are no fixed inclusion criteria for pediatric respiratory ECMO, and ECMO is usually started if there is a high probability of a lethal outcome despite maximal conventional therapy

Read more

Summary

CASE REPORT

Successful use of venovenous extracorporeal membranous oxygenation in a 22-month old boy with necrotizing pneumonia, osteomyelitis and septic shock caused by Panton Valentine leukocidin – producing Staphylococcus aureus.

Introduction
Case report
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call